Welsh, R. C., Roe, M. T., Steg, P. G., James, S., Povsic, T. J., Bode, C., … Ohman, E. M. (2017). Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100]. Am Heart J, 184, 156. https://doi.org/10.1016/j.ahj.2017.01.004

Welsh, Robert C., Matthew T. Roe, Philippe Gabriel Steg, Stefan James, Thomas J. Povsic, Christoph Bode, Charles Michael Gibson, and Erik Magnus Ohman. “Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].” Am Heart J 184 (February 2017): 156. https://doi.org/10.1016/j.ahj.2017.01.004.

Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, et al. Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100]. Am Heart J. 2017 Feb;184:156.

Welsh, Robert C., et al. “Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].” Am Heart J, vol. 184, Feb. 2017, p. 156. Pubmed, doi:10.1016/j.ahj.2017.01.004.

Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, Gibson CM, Ohman EM. Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100]. Am Heart J. 2017 Feb;184:156.